Skeletal muscle atrophy and peak oxygen consumption in heart failure

The American Journal of Cardiology
Michael J TothE T Poehlman

Abstract

We measured skeletal muscle mass and peak oxygen consumption (VO2) in 13 cachectic heart failure patients, 14 noncachectic patients, and in 52 healthy controls to examine skeletal muscle atrophy and its relation to low peak VO2 in heart failure patients. Our results show that skeletal muscle atrophy is associated with prior weight loss and is related to low peak VO2 in heart failure patients.

Citations

May 23, 2014·Diabetologia·Malene N DemantCharlotte Andersson
Jun 8, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·A S RyanA W Gardner
Jan 1, 1999·Progress in Cardiovascular Diseases·A AfzalS J Keteyian
Nov 3, 2010·The Journal of Physiology·Han-Jun WangWei Wang
Aug 21, 2010·The Journal of Physiology·Mark S MillerMichael J Toth
Mar 31, 2009·International Journal of Cardiology·Michael J TothPhilip A Ades
Oct 2, 2007·International Journal of Cardiology·Michel R Hoenig
Oct 2, 2007·Heart Failure Clinics·Jerome L Fleg
Nov 28, 2006·Clinics in Geriatric Medicine·Jerome L Fleg
Jul 14, 2001·Journal of the American College of Cardiology·R Wensel, S D Anker
May 27, 2003·American Heart Journal·Steven J KeteyianWilliam E Kraus
Apr 12, 2003·The American Journal of Medicine·Scott M Grundy
Apr 28, 2006·JPEN. Journal of Parenteral and Enteral Nutrition·Michael J Toth, Dwight E Matthews
Apr 20, 2017·Medicine·Der-Sheng HanWei-Shiung Yang
Sep 13, 2018·American Journal of Physiology. Cell Physiology·Blas A GuigniMichael J Toth
Nov 25, 2004·American Journal of Physiology. Endocrinology and Metabolism·Michael J TothMartin M LeWinter
May 27, 2006·Coronary Artery Disease·Steven J Keteyian
Mar 7, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M J TothE T Poehlman
Feb 26, 2005·The International Journal of Eating Disorders·Mori J KrantzPhilip S Mehler
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·I Bourdel-Marchasson, J P Emeriau
Sep 29, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Alexander Tenenbaum, Enrique Z Fisman
Aug 12, 1999·The Journal of Clinical Endocrinology and Metabolism·M J TothE T Poehlman
Dec 12, 2012·Current Opinion in Clinical Nutrition and Metabolic Care·Damien M Callahan, Michael J Toth
Dec 31, 2015·Current Opinion in Supportive and Palliative Care·Miriam J Johnson, Andrew L Clark
Sep 25, 2009·The American Journal of Clinical Nutrition·Angela Yee-Moon WangJean Woo
Feb 9, 2013·Exercise and Sport Sciences Reviews·Mark S Miller, Michael J Toth
Feb 13, 2003·American Journal of Physiology. Endocrinology and Metabolism·Rebecca PersingerMichael J Toth
May 29, 2004·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Peter J SendenWillem L Mosterd
Dec 28, 2019·International Journal of Molecular Sciences·Spencer G MillerJeffrey J Brault
Jan 19, 2008·Journal of Applied Physiology·Yoko OkadaPeter Vanburen
Jun 12, 2021·Journal of Sport and Health Science·Qi LiuJunjie Xiao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.